Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $465.55 million. The enterprise value is $398.22 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 126.85 million shares outstanding. The number of shares has decreased by -2.00% in one year.
| Current Share Class | 126.85M |
| Shares Outstanding | 126.85M |
| Shares Change (YoY) | -2.00% |
| Shares Change (QoQ) | -4.44% |
| Owned by Insiders (%) | 37.57% |
| Owned by Institutions (%) | 41.96% |
| Float | 55.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 19.24 |
| PS Ratio | 0.93 |
| Forward PS | 0.94 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 104.97 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.87 |
| EV / EBITDA | 17.68 |
| EV / EBIT | 76.71 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.12 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 1.01 |
| Debt / FCF | n/a |
| Interest Coverage | 5.04 |
Financial Efficiency
Return on equity (ROE) is -4.92% and return on invested capital (ROIC) is 0.80%.
| Return on Equity (ROE) | -4.92% |
| Return on Assets (ROA) | 0.70% |
| Return on Invested Capital (ROIC) | 0.80% |
| Return on Capital Employed (ROCE) | 1.29% |
| Revenue Per Employee | $527,917 |
| Profits Per Employee | -$23,507 |
| Employee Count | 869 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 3.88 |
Taxes
| Income Tax | -8.37M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.25% in the last 52 weeks. The beta is 1.63, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | +42.25% |
| 50-Day Moving Average | 3.65 |
| 200-Day Moving Average | 3.63 |
| Relative Strength Index (RSI) | 59.65 |
| Average Volume (20 Days) | 1,008,737 |
Short Selling Information
The latest short interest is 10.81 million, so 8.52% of the outstanding shares have been sold short.
| Short Interest | 10.81M |
| Short Previous Month | 11.49M |
| Short % of Shares Out | 8.52% |
| Short % of Float | 19.53% |
| Short Ratio (days to cover) | 10.89 |
Income Statement
In the last 12 months, ORGO had revenue of $458.76 million and -$20.43 million in losses. Loss per share was -$0.16.
| Revenue | 458.76M |
| Gross Profit | 347.99M |
| Operating Income | 5.19M |
| Pretax Income | n/a |
| Net Income | -20.43M |
| EBITDA | 22.53M |
| EBIT | 5.19M |
| Loss Per Share | -$0.16 |
Full Income StatementBalance Sheet
The company has $109.97 million in cash and $42.63 million in debt, giving a net cash position of $67.33 million or $0.53 per share.
| Cash & Cash Equivalents | 109.97M |
| Total Debt | 42.63M |
| Net Cash | 67.33M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 368.07M |
| Book Value Per Share | 1.91 |
| Working Capital | 203.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.44 million and capital expenditures -$11.44 million, giving a free cash flow of -$7.00 million.
| Operating Cash Flow | 4.44M |
| Capital Expenditures | -11.44M |
| Free Cash Flow | -7.00M |
| FCF Per Share | -$0.06 |
Full Cash Flow StatementMargins
Gross margin is 75.85%, with operating and profit margins of 1.13% and -3.46%.
| Gross Margin | 75.85% |
| Operating Margin | 1.13% |
| Pretax Margin | -5.29% |
| Profit Margin | -3.46% |
| EBITDA Margin | 4.91% |
| EBIT Margin | 1.13% |
| FCF Margin | n/a |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.00% |
| Shareholder Yield | 2.00% |
| Earnings Yield | -4.39% |
| FCF Yield | -1.50% |
Analyst Forecast
The average price target for ORGO is $5.50, which is 49.86% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.50 |
| Price Target Difference | 49.86% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 3.89 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.89 |
| Piotroski F-Score | 6 |
